HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alnawaz Rehemtulla Selected Research

Glioma (Gliomas)

11/2022ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization.
1/2020Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.
7/2014Evaluation of therapeutic effects of natural killer (NK) cell-based immunotherapy in mice using in vivo apoptosis bioimaging with a caspase-3 sensor.
4/2014Apoptosis imaging for monitoring DR5 antibody accumulation and pharmacodynamics in brain tumors noninvasively.
1/2014Noninvasive imaging of apoptosis induced by adenovirus-mediated cancer gene therapy using a caspase-3 biosensor in living subjects.
12/2013Impact of perfusion map analysis on early survival prediction accuracy in glioma patients.
7/2012DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma model.
1/2012DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma.
7/2011Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment.
11/2010Assessment of multiexponential diffusion features as MRI cancer therapy response metrics.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alnawaz Rehemtulla Research Topics

Disease

103Neoplasms (Cancer)
12/2021 - 01/2002
24Glioma (Gliomas)
11/2022 - 11/2004
11Glioblastoma (Glioblastoma Multiforme)
11/2022 - 01/2011
9Neoplasm Metastasis (Metastasis)
01/2015 - 08/2005
8Brain Neoplasms (Brain Tumor)
04/2014 - 04/2005
8Gliosarcoma
07/2012 - 03/2005
7Lung Neoplasms (Lung Cancer)
01/2020 - 08/2005
7Breast Neoplasms (Breast Cancer)
12/2016 - 07/2002
5Pancreatic Neoplasms (Pancreatic Cancer)
11/2020 - 08/2005
5Head and Neck Neoplasms (Head and Neck Cancer)
01/2018 - 05/2010
5Prostatic Neoplasms (Prostate Cancer)
01/2015 - 11/2003
4Adenocarcinoma of Lung
01/2020 - 08/2005
4Colorectal Neoplasms (Colorectal Cancer)
10/2012 - 04/2002
3Ataxia Telangiectasia (Louis Bar Syndrome)
01/2017 - 08/2013
3Adenocarcinoma
04/2010 - 08/2005
3Bone Neoplasms (Bone Cancer)
05/2009 - 04/2007
3Carcinogenesis
05/2007 - 03/2005
2Hypoxia (Hypoxemia)
11/2020 - 03/2005
2Stomatitis
01/2018 - 04/2008
2Mucositis
01/2018 - 04/2008
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2016 - 06/2013
2Disease Progression
02/2015 - 11/2012
2Chronic Obstructive Pulmonary Disease (COPD)
02/2015 - 11/2012
2Ovarian Neoplasms (Ovarian Cancer)
01/2013 - 12/2011
1Bacterial Infections (Bacterial Infection)
01/2022
1COVID-19
01/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2021
1Graft vs Host Disease (Graft-Versus-Host Disease)
11/2021
1Colitis
11/2021

Drug/Important Bio-Agent (IBA)

40Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2004
16Pharmaceutical PreparationsIBA
01/2017 - 04/2002
14Phosphotransferases (Kinase)IBA
01/2017 - 02/2008
10Proteins (Proteins, Gene)FDA Link
11/2022 - 08/2005
8Carmustine (FIVB)FDA Link
11/2010 - 12/2004
6Peptides (Polypeptides)IBA
01/2021 - 08/2005
6Caspase 3 (Caspase-3)IBA
01/2021 - 04/2008
6Biological ProductsIBA
01/2018 - 11/2003
6Fluorouracil (Carac)FDA LinkGeneric
04/2010 - 04/2002
5Therapeutic UsesIBA
01/2021 - 01/2002
5Temozolomide (Temodar)FDA LinkGeneric
01/2019 - 05/2007
5DNA (Deoxyribonucleic Acid)IBA
01/2019 - 08/2005
5Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2017 - 07/2008
5LuciferasesIBA
11/2015 - 10/2011
5Cisplatin (Platino)FDA LinkGeneric
02/2014 - 04/2008
5Cytosine DeaminaseIBA
12/2008 - 04/2002
4FurinIBA
01/2022 - 05/2007
4CaspasesIBA
11/2020 - 04/2010
4EnzymesIBA
01/2020 - 04/2002
4Peptide Hydrolases (Proteases)FDA Link
01/2018 - 05/2007
4Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2011 - 09/2007
4Messenger RNA (mRNA)IBA
11/2005 - 07/2002
4ProdrugsIBA
03/2005 - 04/2002
3GemcitabineFDA Link
11/2020 - 06/2011
3Transcription Factors (Transcription Factor)IBA
01/2015 - 04/2010
3Antineoplastic Agents (Antineoplastics)IBA
02/2014 - 07/2005
3geldanamycinIBA
02/2014 - 08/2012
3Docetaxel (Taxotere)FDA Link
12/2012 - 04/2007
3ErbB Receptors (EGF Receptor)IBA
08/2012 - 05/2008
3perifosineIBA
12/2011 - 04/2008
3beta-Galactosidase (Lactaid)IBA
07/2010 - 02/2003
3Flucytosine (Ancobon)FDA Link
12/2008 - 04/2002
3Protons (Proton)IBA
12/2006 - 01/2005
3SodiumIBA
12/2006 - 01/2005
2Protein Disulfide-IsomerasesIBA
01/2019 - 01/2019
2Methionine (L-Methionine)FDA Link
01/2018 - 04/2008
2Tyrosine Kinase InhibitorsIBA
10/2016 - 08/2012
2AntibodiesIBA
09/2015 - 05/2009
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
04/2015 - 05/2012
2Hormones (Hormone)IBA
01/2015 - 04/2007
2Indicators and Reagents (Reagents)IBA
10/2014 - 04/2005
2Renilla LuciferasesIBA
07/2014 - 01/2014
2LigandsIBA
01/2014 - 03/2007
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2014 - 03/2007
2tyrosine receptor (receptor, tyrosine)IBA
06/2013 - 05/2008
2Sirolimus (Rapamycin)FDA Link
10/2012 - 12/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2012 - 03/2006
2NF-kappa B (NF-kB)IBA
04/2010 - 08/2005
2Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
06/2009 - 03/2005
2Matrix Metalloproteinases (MMPs)IBA
06/2009 - 04/2008
21-phenyl-3,3-dimethyltriazene (PDT)IBA
04/2007 - 11/2006
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
11/2022
1ChromatinIBA
11/2022
1Immune Checkpoint InhibitorsIBA
11/2021
1Succinic Acid (Succinate)IBA
11/2021
1Firefly LuciferasesIBA
01/2021
1Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
01/2021
1TAK-243IBA
11/2020
1Mechanistic Target of Rapamycin Complex 2IBA
01/2020
1Calcitriol (Calcijex)FDA LinkGeneric
01/2020
1Cytochrome P450 Family 24IBA
01/2020
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2020
1Anaphase-Promoting Complex-CyclosomeIBA
01/2020

Therapy/Procedure

63Therapeutics
11/2022 - 01/2002
16Drug Therapy (Chemotherapy)
01/2018 - 01/2005
10Radiotherapy
08/2019 - 04/2008
5Aftercare (After-Treatment)
08/2012 - 07/2005
4Neoadjuvant Therapy
01/2015 - 01/2007
3Chemoradiotherapy
01/2018 - 12/2008
2Intravenous Injections
01/2021 - 08/2005
2Precision Medicine
12/2013 - 12/2010